Viewing Study NCT02502903


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-01-05 @ 5:22 PM
Study NCT ID: NCT02502903
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2015-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Sponsor: Bioverativ, a Sanofi company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module